Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Antal Péter is active.

Publication


Featured researches published by Antal Péter.


Pathology & Oncology Research | 2003

Influence of Obesity on Lymph Node Recovery from Rectal Resection Specimens

Dénes Görög; Péter Nagy; Antal Péter; Ferenc Perner

Careful lymph node dissection from colorectal resection specimens is important procedure for cancer staging. Present study intended to assess the impact of surgical technique and patient’s obesity on this process. Number of lymph nodes harvested by manual dissection from resection specimens of 141 patients with rectal cancer and the rate of nodal metastases were analyzed and compared in different groups of patients selected by length of resection specimen and body mass index. The median and mean number of lymph nodes found per patient were 6 and 6,7. The shorter resection specimens (≤16 cm after formalin fixation) yielded significantly lower number of nodes than those with length > 16 cm (5.7 versus 7.9). Most significant reduction in mean number of lymph nodes was observed in obese patients with short specimens (4.8). This subset of patients presented the lowest rate of nodal metastases (38%). The surgical technique seems to be an important factor for lymph node recovery from rectal resections specimens. The patient’s obesity had an unfavourable impact on this procedure. Standardized surgery and histopathological examination are needed even in non-specialized centers to harvest adequate number of lymph nodes.


Clinical Transplantation | 2004

Endoscopic diagnosis of cytomegalovirus infection of upper gastrointestinal tract in solid organ transplant recipients: Hungarian single-center experience

Antal Péter; Gábor Telkes; Marina Varga; E. Sárváry; Ilona Kovalszky

Abstract:  Background:  Cytomegalovirus (CMV) is considered to be the major cause of upper gastrointestinal (GI) symptoms in organ transplant recipients. In the diagnosis of GI CMV infection the detection of the virus in the mucosa is essential. The aim of the study was to evaluate the significance of CMV, detected in biopsy specimens from stomach and duodenum of solid organ transplant recipients.


Transplantation Proceedings | 2011

Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis.

G. Végsö; Éva Toronyi; M. Hajdu; L. Piros; Dénes Görög; Pál Ákos Deák; Attila Doros; Antal Péter; R.M. Langer

INTRODUCTION The frequency of malignant tumors as a cause of death is increasing among kidney transplant patients. The aim of our study was to characterize kidney tumors occurring in the native kidneys of renal transplanted patients, and to determine their impact on recipient survival. METHODS We retrospectively analyzed the 43/3003 (1.43%) renal cell carcinomas (RCC) in the native kidneys of patients transplanted between 1973 and 2010. RESULTS During this period we diagnosed 293 posttransplant tumors, 14.6% of which were RCC. The male/female ratio was 2.1:1. The mean age of recipients at the time of tumor detection was 52.4 ± 12.1 years. The mean time from transplantation to diagnosis was 72.4 ± 61.6 months. RCC occurred on both sides in similar numbers. Tumors were multifocal in 8 cases. According to TNM staging, RCC was stage I in 38 cases. The histologic type was clear cell (n=27), papillary (n=13), chromophobe (n=2) or sarcomatoid (n=1). Radical nephrectomy was performed in 41 cases. Immunosuppressive management was converted to proliferation signal inhibitors in 27 patients (sirolimus n=19 or everolimus n=8). Fifteeen patients died at a mean survival time of 38.9 ± 62.4 months with 28 patients still alive at a mean follow-up 43.8 ± 35.6 months. Cumulative survival according to the Kaplan-Meier method was 79.2% at 1 year, 66.1% at 5 years, and 59.0% at 10 years. The patient survival rate was better among papillary than clear cell RCC (P=.038). CONCLUSION RCC was the second most frequent tumor among kidney transplanted patients at our center. The diagnosis established at an early stage in the majority of cases, leading to favorable patient survivals. A regular yearly abdominal ultrasound screening is suggested for early tumor diagnosis.


Transplant Infectious Disease | 2005

Comparing cytomegalovirus prophylaxis in renal transplantation: single center experience

Marina Varga; Adam Remport; Márta Hídvégi; Antal Péter; László Kóbori; Gábor Telkes; János Fazakas; Zsuzsanna Gerlei; E. Sárváry; B. Sulyok; J. Járay

Abstract: Background: Cytomegalovirus (CMV) presents a serious threat to CMV‐seronegative recipients (R−), who have received an organ from a seropositive donor (D+).


Nephrology Dialysis Transplantation | 2008

HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients

Marina Varga; Katalin Rajczy; Gábor Telkes; Márta Hídvégi; Antal Péter; Adam Remport; Márta Korbonits; János Fazakas; Éva Toronyi; E. Sárváry; László Kóbori; Jeno Járay

BACKGROUND Cytomegalovirus (CMV) infection in transplant patients with special risk factors remains a major hazard. CMV-seronegative recipients with seropositive donors have the highest risk of developing acute CMV disease. We suggest that the HLA-type may influence the occurrence and the severity of primary CMV infection of these recipients and the measurement of the special HLA-types may be useful in the prediction of acute infection. METHODS Since 1999 1213 cadaver kidney transplantations have been performed in our clinic. 163 of 1213 recipients were CMV-seronegative (13%) and 129 of them received the kidney from seropositive donors. All 129 patients received CMV infection prophylaxis. Of 129 CMV-seronegative patients 49 developed acute CMV infection (38%) during the first posttransplant year. CMV infection was diagnosed by CMV antigenemia test and serologic measurements (ELISA). The particular HLA-genotypes of the recipients were studied before the transplantation. The occurrence and the severity of CMV infection was investigated in association with HLA-types. RESULTS We found different acute CMV infection distribution in the careers and non-careers of investigated HLA-types: HLA-A2, HLA-B12, HLA-Cw7, HLA-DR6 and HLA-DR11, but the differences were not significant in these HLA-types (P = 0.26, P = 0.37, P = 0.83, P = 0.07 and P = 0.37). While investigating HLA-DQ3, we found that of 68 DQ3-positive patients 32 (47%), of 61 DQ3-negative patients 17 (28%) had acute CMV infection and this difference was found to be significant. This result was confirmed by univariate and multivariate Cox Regression (P = 0.001) and the appropriate significance level was considered by Bonferroni correction. CONCLUSIONS HLA-DQ3 was found to be an independent predictor of CMV infection. Our data suggest that patients positive for HLA-DQ3 are more susceptible to CMV infection than a comparable group of patients negative for HLA-DQ3. This result was not due to rejection and/or treatment for rejection and was not influenced by induction therapy. Although we found more symptomatic infections among DQ3+ patients the difference was not significant (P = 0.19). Comparing the gender proportion among all 1213 kidney recipients and among CMV-seronegative recipients we found that the proportion of males is significantly higher among CMV-seronegative recipients (P < 0.001).


European Journal of Gastroenterology & Hepatology | 2008

Seroprevalence of Helicobacter pylori in Central-European uraemic patients and its possible association with presence of HLA-DR12 allele.

Gábor Telkes; Katalin Rajczy; Marina Varga; Antal Péter; Zsolt Tulassay

Objectives Renal disease at any stage is often accompanied by significant gastrointestinal symptoms, and Helicobacter pylori (H. pylori) is closely related to these disorders. A debate is still ongoing on the clinical significance of coexisting uraemia and H. pylori. HLA-class II genes have been repeatedly investigated for predisposition to H. pylori infection. The aim of our work was to evaluate the infection rate among uraemic patients, and study the relationship between HLA antigens and H. pylori serologic status in the same cohort. Materials and methods Data of 709 uraemic patients were collected and analyzed from 2001–2006. 58.7% of patients were male, 41.3% were female, mean age was 45.1 years (SD: ±14.65). Microlymphocytotoxicity assay was used for typing of HLA class I, PCR-SSP for typing HLA class II alleles and enzyme immunofluorescency for specific H. pylori IgG. Results Of 709 patients, 49.37% were seropositive for H. pylori. Age of H. pylori positive patients was 48.9 versus 41 years of negatives (P<0.0001). Prevalence of H. pylori decreased strongly with year of birth. Significant difference was observed in the occurrence of HLA-DR12 according to H. pylori serology. Of patients carrying DR12, 27 (73%) were H. pylori positive and 10 (27%) were negative [P=0.0037; risk ratios (RR): 2.76]. Conclusion H. pylori infection rate and its decrease with year of birth was the same in the uraemic patients and in the normal population, according to specific prevalence figures. Frequency of HLA-DR12 was the same as in the general population; consequently, it might be a possible risk factor for H. pylori seropositivity, at least in a Central-European population.


Surgery Today | 2004

Single-layer continuous suturing for end-to-end colonic anastomosis using a modified closed-bowel technique.

Dénes Görög; Antal Péter; József Szabó; Ferenc Perner

We describe our modified technique of performing one-layer continuously sutured colonic anastomosis, which we introduced in 1995. We also present the preliminary results of performing end-to-end intra-abdominal colonic anastomosis constructed by single-layer continuous suturing using the closed-bowel technique in 106 patients. Mortality was 2.8%, the incidence of early postoperative surgical complications was 3.8% [including anastomotic leakages (1.9%)], and the rate of reoperation for infective complications was 2.8%. These positive results show that this is an effective method of performing end-to-end colonic anastomosis. We think that our technical modification provides advantages for one-layer continuously sutured colonic anastomosis.


Transplantation Proceedings | 2011

Cytomegalovirus Seroprevalence Among Solid Organ Donors in Hungary: Correlations With Age, Gender, and Blood Group

Marina Varga; Dénes Görög; D. Kári; E. Környei; É. Kis; H.J. Túryné; I. Jankovics; Antal Péter; Éva Toronyi; Enikő Sárváry; János Fazakas; Gy. Reusz


Orvosi Hetilap | 2008

[Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].

Marina Varga; Adam Remport; Krisztina Czebe; Antal Péter; Éva Toronyi; Enikő Sárváry; Imre Fehérvári; Beáta Sulyok; J. Járay


Nephrology Dialysis Transplantation | 2011

High frequency of ulcers, not associated with Helicobacter pylori, in the stomach in the first year after kidney transplantation

Gábor Telkes; Antal Péter; Zsolt Tulassay; Argiris Asderakis

Collaboration


Dive into the Antal Péter's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Járay

Semmelweis University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zsolt Tulassay

Hungarian Academy of Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge